Axtria

Axtria, founded in 2010 by Jaswinder Chadha, is a data analytics and cloud software company specializing in AI-driven solutions for the life sciences industry.

Reviewed by 7wData
Share Email

On this page

Profile

Axtria provides AI-driven data analytics and cloud software to help life sciences companies improve patient outcomes by connecting therapies to patients more effectively.

Axtria, founded in 2010 by Jaswinder Chadha, is a data analytics and cloud software company specializing in AI-driven solutions for the life sciences industry. Headquartered in Berkeley Heights, New Jersey, the company has grown to serve 18 of the top 20 global pharmaceutical companies, with a presence in over 75 countries. Axtria's focus on AI and machine learning has positioned it as a key player in transforming life sciences commercialization, from data management to decision-making.

In September 2025, Axtria secured a $240 million investment from Kedaara Capital, one of the largest employee-centric liquidity events in the industry, underscoring its financial trajectory and commitment to its workforce. The company's recent acquisition of Conexus Solutions in 2026 further expanded its CRM capabilities in life sciences. Axtria's flagship product, Axtria InsightsMAx.ai, is an agentic platform with 30+ ready-to-deploy agents, apps, and APIs, designed to move companies from AI experimentation to scaled deployment. The company has been recognized in Gartner's Hype Cycle reports for Life Science Enterprise Technologies and Healthcare and Life Science Data, Analytics, and AI in 2025.

Track Axtria and 240+ vendors.

48k+ subscribers read the daily AI & data note. One email, both newsletters. Unsubscribe anytime.

Products by Axtria

Who buys this

  • Global pharmaceutical companies
  • Medical device manufacturers
  • Biopharma firms
  • Diagnostics companies
  • Life sciences commercial operations teams

Strengths and what to watch

Strengths

  • Deep domain expertise in life sciences, serving 18 of the top 20 global pharmaceutical companies.
  • Strong financial backing with a $240 million investment from Kedaara Capital in 2025.
  • Integrated AI-native platform (Axtria InsightsMAx.ai) with 30+ ready-to-deploy agents and APIs.

Watch for

  • Dependence on the life sciences sector, which is highly regulated and subject to market fluctuations.
  • Integration challenges post-acquisition of Conexus Solutions, which could strain resources.
  • Competition from larger enterprise software providers expanding into AI-driven life sciences solutions.

Recent moves

Key Information

Founded
2010
Headquarters
Berkeley Heights, New Jersey

Frequently Asked Questions

What does Axtria do?

Axtria provides AI-driven data analytics and cloud software to help life sciences companies improve patient outcomes. Their solutions connect therapies to patients more effectively, focusing on data management and decision-making for global pharmaceutical and biopharma firms.

What is Axtria InsightsMAx.ai?

Axtria InsightsMAx.ai is an AI-native platform with 30+ ready-to-deploy agents, apps, and APIs. It helps life sciences companies transition from AI experimentation to scaled deployment, enhancing commercialization efforts through advanced data analytics and decision-making tools.

Who are Axtria's main customers?

Axtria serves 18 of the top 20 global pharmaceutical companies, along with medical device manufacturers, biopharma firms, diagnostics companies, and life sciences commercial operations teams. Their solutions are tailored to meet the needs of these highly regulated industries.

What recent investments has Axtria secured?

In September 2025, Axtria secured a $240 million investment from Kedaara Capital, one of the largest employee-centric liquidity events in the industry. This investment underscores Axtria's financial trajectory and commitment to its workforce.

What recent acquisitions has Axtria made?

Axtria expanded its CRM capabilities in life sciences by acquiring Conexus Solutions in 2026. This acquisition enhances their ability to provide integrated AI-driven solutions for customer relationship management in the pharmaceutical and biopharma sectors.

How does Axtria support life sciences companies?

Axtria supports life sciences companies with AI-driven data analytics and cloud software, improving patient outcomes by connecting therapies to patients more effectively. Their solutions focus on data management, decision-making, and commercialization strategies tailored to the industry's needs.

Sources

  1. www.prnewswire.com — $240 million investment from Kedaara Capital
  2. www.prnewswire.com — Axtria's flagship product Axtria InsightsMAx.ai
  3. www.prnewswire.com — Axtria Ignite Global 2026 event
  4. www.axtria.com — Acquisition of Conexus Solutions